Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • eab
    Member
    • May 2011
    • 66

    #1

    RNASeq by Nextera vs. Standard

    Does anyone out there strongly prefer either Nextera or standard (TruSeq) library construction for RNAseq?

    I use a version of the standard protocol, which is familiar to me, not fast but automatable, cheap-ish, and comes with a bit of insert-end bias that I understand is due to bias in random hexamer synthesis or priming.

    My sense is that the Nextera protocol is faster, more expensive in consumables ($80/sample for Illumina kit), and generates a longer region of insert-end bias which theoretically causes greater skewing of expression data.

    Agree?

    Disagree?

    Why?
  • SS00
    PhD Student
    • Jun 2012
    • 33

    #2
    Interested in this too. Currently testing protocols for Low Input RNA-Seq (500pg-2ng) and have been recommended the TotalScript Nextera by some colleagues.

    Up until now I have been testing the SMARTer PolyA kit, but have been told Nextera TotalScipt allows Low Input Total RNA-Seq plus it's easier. I am not sure if the data will look as good as the SMARTer and honestly don't mind extra lab work if my sequencing data is better. Just looking at their protocol I see I have to decide between even coverage with 45% rRNA reads or low rRNA reads with 3' bias - not impressed!

    Anyone have experience with the TotalScript kit or Nextera RNA-seq in general?

    Sidenote: With such a low yield of RNA in a quiescent cell type (stem cells) I am worried doing Total RNA-seq will simply add to the ''noise'' in my analysis and make it harder to detect changes in lower-expressed RNA's. Any advice to this?

    Sorry to hijack your thread eab!

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...